본문으로 바로가기
현재 위치:
Home
진료과
산부인과
주웅
관심콘텐츠
프린트

의료진 소개

진료과 의료진
주웅 의사

주웅 교수

산부인과, 로봇수술센터 관심의료진 등록

전문 진료 분야

부인암 클리닉 ※암 진단 받은 신환만 예약 가능

진료 일정

진료예약 간편 예약 고맙습니다

학력사항

  • 하버드대 보건대학원 졸업/MPH 
  • 하버드의대 Massachusetts General Hospital, Center for Connected Health, Visiting Scholar 
  • 하버드의대 Brigham and Women's Hospital Channing Laboratory, Visiting Scholar 
  • 뉴욕 Memorial Sloan-Kettering Cancer Center 연수 
  • 서울대학교 대학원 의학박사 
  • 서울대학교 대학원 의학석사 
  • 서울대학교 의과대학 졸업

교육 및 연구경력

  • 2024-현재  | 이대서울병원장
  • 2022-2024  | 이대서울병원 진료부원장
  • 2021-2022  | 이대서울병원 첨단의생명연구원장
  • 2020-2021  | 이대서울병원 스마트의료센터장
  • 2016-현재  | 이화여자대학교 의과대학 산부인과학교실 교수
  • 2015-2017  | 이대목동병원 진료협력센터장
  • 2015-2017  | 이대여성암병원 부인종양센터장
  • 2014-현재  | 이대목동병원 공공의료교육사업센터장
  • 2014-2018  | 이화여자대학교 의학전문대학원/의과대학 교무차장
  • 2014-2015  | 이화의료원 홍보실장

수상경력

  • 2016 | 한국보건의료기술평가학회 올해의 논문상
  • 2014 | Best Poster Award, AOGIN (Asia Oceania research organisation on Genital Infections and Neoplasia)
  • 2013 | 대한산부인과학회 추계학술대회 최우수구연상
  • 2010 | 이화의료원 모범교수상(연구 부문)
  • 2008 | 대한산부인과학회 추계학술대회 최우수구연상
  • 2005 | 대한부인종양학회 춘계학술대회 BMS 우수논문상
  • 2005 | Young Gynecologist Award, Asia and Oceanic Congress of Obstetrics and Gynecology, Seoul, Korea
  • 2004 | AACR-Avon Scholar-in-Training Award, AACR Frontiers in Cancer Prevention Research Conference, Seattle, WA
  • 2003 | 대한산부인과내시경학회 학술상
  • 2002 | 서울의대 산부인과학교실 최우수 전공의상

기타 학술 관련 경력

  • 2015-현재  | 대한의학회 임상진료지침 전문위원
  • 2017-2019  | 대한산부인과학회 사무총장

논문

  •  Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.  Yonsei Medical Journal. 2014, v.55 no.5, 1206-1213. 
  •  Leisure-time physical activity and endometrial cancer risk : Dose-response meta-analysis of epidemiological studies.  INTERNATIONAL JOURNAL OF CANCER. 2014, v.135 no.3, 682-694. 
  •  HIV-1 tat protein promotes amyloid β generation and tau phosphorylation in rat hippocampal slices.  Journal of Bacteriology and Virology. 2014, v.44 no.1, 102-107. 
  •  Differential level of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer.  CANCER RESEARCH. 2014, v.74 no.19. 
  •  DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.  Yonsei Medical Journal. 2014, v.55 no.6, 1656-1663. 
  •  Calcium intake and colorectal cancer risk: Dose-response meta-analysis of prospective observational studies.  International Journal of Cancer. 2014, v.135 no.8, 1940-1948. 
  •  Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis.  ONCOLOGY REPORTS. 2014, v.31 no.3, 1417-1422. 
  •  Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells.  Oncology Reports. 2014, v.32 no.2, 815-820. 
  •  Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer.  ONCOLOGY REPORTS. 2014, v.31 no.5, 2139-2146. 
  •  The effect of technology-based interventions on pain, depression, and quality of life in patients with cancer: A systematic review of randomized controlled trials.  Journal of Medical Internet Research. 2015, v.17 no.3. 
  •  Prospective study of body fat distribution and the risk of endometrial cancer.  Cancer Epidemiology. 2015, v.39 no.4, 567-570. 
  •  Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: Importance of positive or close parametrial resection margin.  Radiation Oncology Journal. 2015, v.33 no.2, 109-116. 
  •  MICRONUTRIENTS AND CLEARANCE OF HUMAN PAPILLOMAVIRUS: A META-ANALYSIS.  INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2015, v.25 no.9, 335-335. 
  •  Asian society of gynecologic oncology international workshop 2014.  Journal of Gynecologic Oncology. 2015, v.26 no.1, 68-74. 
  •  Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.  Journal of the National Cancer Institute. 2015, v.107 no.2. 
  •  A lectin-based diagnostic system using circulating antibodies to detect cervical intraepithelial neoplasia and cervical cancer.  Glycobiology. 2015, v.26 no.1, 100-107. 
  •  공공보건의료인력 임상교육효과 평가: 지역거점공공병원 간호사 대상.  보건행정학회지. 2016, v.26 no.4, 373. 
  •  Treatment outcomes after adjuvant radiotherapy following surgery for patients with stage i endometrial cancer.  Radiation Oncology Journal. 2016, v.34 no.4, 265-272. 
  •  Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.  ONCOLOGY REPORTS. 2016, v.36 no.1, 535-541. 
  •  Preventive vaccination against cervical cancer: Korean society of gynecologic oncology guideline.  Journal of Gynecologic Oncology. 2016, v.27 no.3. 
  •  Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline.  Journal of Gynecologic Oncology. 2016, v.27 no.3, 1~14. 
  •  Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System A Korean Gynecologic-Oncology Group Study.  INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2016, v.26 no.4, 711-715. 
  •  Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.  Archives of Pharmacal Research. 2016, 22 MAR 2016, 1-9. 
  •  Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix.  CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2016, v.54 no.11, 1811-1819. 
  •  Current trend in translational research for treatment of ovarian cancer.  JOURNAL OF THE KOREAN MEDICAL ASSOCIATION. 2016, v.59 no.3, 189-193. 
  •  Cervical cancer screening in developing countries: Using visual inspection methods.  Clinical Journal of Oncology Nursing. 2016, v.20 no.1, 79-84. 
  •  Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer.  Obstetrics & Gynecology Science. 2016, v.59 no.4, 279~285. 
  •  Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.  Oncotarget. 2017, v.8 no.62, 105425-105439. 
  •  Two-step chromatographic purification of glutathione S-transferase-tagged human papillomavirus type 16 E6 protein and its application for serology.  Protein Expression and Purification. 2017, v.132, 19-26. 
  •  Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.  Oncotarget. 2017, v.8 no.4, 6608-6622. 
  •  Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: A prospective randomized controlled study.  Journal of Gynecologic Oncology. 2017, v.28 no.3. 
  •  Practice guidelines for management of uterine corpus cancer in Korea: A korean society of gynecologic oncology consensus statement.  Journal of Gynecologic Oncology. 2017, v.28 no.1. 
  •  Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.  EXPERIMENTAL AND MOLECULAR MEDICINE. 2017, v.49. 
  •  Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.  YONSEI MEDICAL JOURNAL. 2017, v.58 no.1, 27-34. 
  •  A cross-sectional study estimating the burden of illness related to genital warts in South Korea.  BMJ OPEN. 2017, v.7 no.6. 
  •  Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer.  ARCHIVES OF PHARMACAL RESEARCH. 2018, v.41 no.4, 438-449. 
  •  Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.  CANCER MEDICINE. 2018, v.7 no.11, 5655-5664. 
  •  Epigenetic modification of alpha-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer.  KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2018, v.22 no.1, 43-51. 
  •  Cardiovascular disease risk factors and obesity levels in Korean adults: Results from the Korea national health and nutrition examination survey, 2007-2015.  Osong Public Health and Research Perspectives. 2018, v.9 no.4, 150-159. 
  •  Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.  Diagnostic Cytopathology. 2018, v.46 no.1, 15-21. 
  •  14-3-3 zeta Overexpression is Associated with Poor Prognosis in Ovarian Cancer.  YONSEI MEDICAL JOURNAL. 2018, v.59 no.1, 51-56. 
  •  Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening.  ONCOLOGY LETTERS. 2019, v.18 no.1, 255-264. 
  •  Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.  EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2019, v.234, 112-116. 
  •  SPSB1 enhances ovarian cancer cell survival by destabilizing p21.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2019, v.510 no.3, 364-369. 
  •  Nonsurgical treatments for patients with radicular pain from lumbosacral disc herniation.  SPINE JOURNAL. 2019, v.19 no.9, 1478-1489. 
  •  Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea.  BMJ OPEN. 2019, v.9 no.3, e025035. 
  •  Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline.  JOURNAL OF GYNECOLOGIC ONCOLOGY. 2019, v.30 no.2, e31. 
  •  낙태법 개정 관련 의료적 이슈와 산부인과의 입장.  한국모자보건학회지. 2020, v.24 no.1, 9-17. 
  •  Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.  Journal of Obstetrics and Gynaecology. 2020, v.40 no.2, 240-246. 
  •  Comparative Efficacy of Targeted Therapies in Patients with Non-Small Cell Lung Cancer: A Network Meta-Analysis of Clinical Trials.  JOURNAL OF CLINICAL MEDICINE. 2020, v.9 no.4, 1063. 
  •  Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines.  JOURNAL OF GYNECOLOGIC ONCOLOGY. 2021, v.32 no.6, e94. 
  •  Necessity for immediate referral to colposcopy according to human papillomavirus (HPV) genotypes in negative-cytology women.  EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2021, v.42 no.6, 1166-1171. 
  •  Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial.  EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2021, v.22 no.1, 787. 
  •  Comparison of machine and deep learning for the classification of cervical cancer based on cervicography images.  Scientific Reports. 2021, v.11 no.1, 16143. 
  •  RGB Channel Superposition Algorithm with Acetowhite Mask Images in a Cervical Cancer Classification Deep Learning Model.  Sensors. 2022, v.22 no.9, 3564.